Jadpro: Managing Classical Hodgkin Lymphoma With Antibodydrug Conjugates

Amy Goodrich, RN, MSN, CRNP-AC, and Nadia Khan, MD, discuss the role of antibody–drug conjugates in the treatment of classical Hodgkin lymphoma, including mechanism of action, recent approvals, emerging data, and expert guidance on clinical application.Instructions for CE credit:If you would like to earn credit, you must take the pre-test first by visiting https://education.annenberg.net/5701-EM1To finish earning credit, you must take the post-test by visiting https://education.annenberg.net/node/9807/take/1